Experimental pill promises new hope for deadly cancer
A new pill, daraxonrasib, nearly doubled survival for advanced pancreatic cancer patients in a major clinical trial.
Original Source
Read the full article at Cleveland →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.